4 completed, 4 unknown, 1 not yet recruiting, 1 withdrawn. 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow genetic: new trials by email Literature Review of genetic trials Research Report on genetic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High Depth Exome Sequencing on DNA From a Salivary Sample by Mouth Smear. genetic - Neurodevelopmental Disorders, Intellectual Developmental Disorder | Not yet recruiting | Centre Hospitalier Universitaire de Besancon | 50 | 2026-04-01 | 2026-04-14 | |
| Use of Personalized Recommendations, Through Genetic and Lifestyle Data, to Improve Healthcare Staff Wellbeing Genetic - Well-Being, Psychological | Not applicable | Unknown | FitnessGenes Ltd. | 500 | 2025-01-01 | 2024-02-28 |
| Lean Diabetes Study Genetic, Social habits, Perinatal stress - Lean Diabetes Mellitus | Withdrawn | Leon Fogelfeld MD | 2022-03-15 | 2024-07-25 | ||
| P-glypoprotein Inhibition Effect on the Pharmacokinetics of Two Tacrolimus Formulations: Prolonged and Extended-release Treatment A, Treatment B, Treament C - Pharmacokinetics | Phase 2 | Completed | Rennes University Hospital | 27 | 2022-02-15 | 2024-12-11 |
| Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection) GENETIC - Covid19 | Unknown | Hospices Civils de Lyon | 40 | 2020-12-01 | 2020-11-25 | |
| Familial Hypercolerstremia as Risk Factor in Stemi Patient Who Underwent Ppci Genetic - Familial Hypercholesterolemia | Unknown | Assiut University | 2 | 2020-11-01 | 2021-06-07 | |
| Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen Tamoxifen 20 mg - Breast Cancer | Unknown | Assiut University | 100 | 2019-09-01 | 2019-07-08 | |
| Familial Analysis of Keratoconus Risk genetic - Keratoconus | Completed | University Hospital, Bordeaux | 95 | 2014-11-25 | 2017-11-13 | |
| Corpus Callosum Agenesis and Intellectual Disability Genetic - Intellectual Deficiency, Cerebral Abnormality | Completed | Assistance Publique - Hôpitaux de Paris | 360 | 2012-01-01 | 2014-06-19 | |
| Communicating Risk Information for Obesity Genetic, Lifestyle - Obesity | Not applicable | Completed | Boston University | 798 | 2011-09-01 | 2017-03-14 |
Agenesis of Corpus Callosum (1) · Breast Neoplasms (1) · COVID-19 (1) · Congenital Abnormalities (1) · Disease Susceptibility (1) · Health Behavior (1) · Hyperlipoproteinemia Type II (1) · Intellectual Disability (1) · Keratoconus (1) · Neurodevelopmental Disorders (1) · Obesity (1) · Psychological Well-Being (1)
Assiut University (2) · Assistance Publique - Hôpitaux de Paris (1) · Boston University (1) · Centre Hospitalier Universitaire de Besancon (1) · FitnessGenes Ltd. (1) · Hospices Civils de Lyon (1) · Leon Fogelfeld MD (1) · Rennes University Hospital (1) · University Hospital, Bordeaux (1)
France (4) · United States (2) · Egypt (1)
Amira Taha (1) · Catharine Wang, PhD, MSc (1) · David Touboul, MD (1) · Ehab Eldesoky (1) · Mohammad Hareedy (1) · Stuart Grice, DPhil (1)
R21HG006073 (1)